NCT07000071

Brief Summary

The aim of the present work is to compare between various modes of non-invasive respiratory support (including NCPAP, NIPPV, and NHFOV) as secondary respiratory support modes in late preterm and term neonates as regards the need for reintubation. Additionally, the study aims at comparing between the three modes concerning the associated morbidity and mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2022

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

May 23, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 31, 2025

Completed
Last Updated

May 31, 2025

Status Verified

January 1, 2025

Enrollment Period

6 months

First QC Date

May 23, 2025

Last Update Submit

May 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Failure rate

    need for reintubation and invasive mechanical ventilation

    72 hours after weaning

Secondary Outcomes (1)

  • duration of non-invasive ventilation

    first 72 hours after weaning from mechanical ventillation

Study Arms (3)

Nasal Continuous positive airway pressure (NCPAP)

ACTIVE COMPARATOR

apply continuous positive airway pressure using nasopharyngeal interface. positive end expiratory pressure (PEEP ) used 5-7 cm H2O. Neonates will be supported with NCPAP following extubation.

Device: NCPAP

Nasal intermittent pressure ventilation (NIPPV)

ACTIVE COMPARATOR

Neonates will be supported with NIPPV following extubation.

Device: NIPPV

Nasal high frequency ventilation (NHFOV)

ACTIVE COMPARATOR

Neonates will be supported with NHFOV following extubation. stating mean airway pressure 8 and can reach upto 15 cm H2O Delta pressure used is 20 Frequency 10 HZ

Device: NHFOV

Interventions

NCPAPDEVICE

Apply nasal continuous positive airway pressure in intubated patients with respiratory distress at time of weaning

Nasal Continuous positive airway pressure (NCPAP)
NIPPVDEVICE

Apply nasal intermittent positive pressure ventilation in intubated patients with respiratory distress at time of weaning

Nasal intermittent pressure ventilation (NIPPV)
NHFOVDEVICE

Apply nasal high frequency ventilation in intubated patients with respiratory distress at time of weaning

Nasal high frequency ventilation (NHFOV)

Eligibility Criteria

Age1 Day - 14 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • The gestational age (GA) is between 34 and 41 weeks.
  • Extubation from invasive mechanical ventilation initiated due to RD, irrespective to the cause of RD.
  • Respiratory distress is assessed based on clinical manifestations (tachypnea, nasal flaring, intercostal retractions, diminished air entry, and or grunting)

You may not qualify if:

  • Major congenital anomalies.
  • Major cardiac diseases.
  • Presence of cardiovascular instability (sepsis, severe dehydration, severe anemia).
  • Neurologically insulted neonates who are unable to take adequate spontaneous breathing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marwa Mohamed Farag

Alexandria, 0325, Egypt

Location

MeSH Terms

Conditions

Dyspnea

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor of Pediatrics

Study Record Dates

First Submitted

May 23, 2025

First Posted

May 31, 2025

Study Start

July 1, 2021

Primary Completion

December 30, 2021

Study Completion

January 30, 2022

Last Updated

May 31, 2025

Record last verified: 2025-01

Locations